Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors.
The mucin-type glycoprotein podoplanin is specifically expressed by lymphatic but not blood vascular endothelial cells in culture and in tumor-associated lymphangiogenesis, and podoplanin deficiency results in congenital lymphedema and impaired lymphatic vascular patterning. However, research into the biological importance of podoplanin has been hampered by the lack of a generally available antibody against the human protein, and its expression in normal tissues and in human malignancies has remained unclear. We generated a human podoplanin-Fc fusion protein and found that the commercially available mouse monoclonal antibody D2-40 specifically recognized human podoplanin, as assessed by enzyme-linked immunosorbent assay and Western blot analyses. We found that, in addition to lymphatic endothelium, podoplanin was also expressed by peritoneal mesothelial cells, osteocytes, glandular myoepithelial cells, ependymal cells, and by stromal reticular cells and follicular dendritic cells of lymphoid organs. These findings were confirmed in normal mouse tissues with anti-podoplanin antibody 8.1.1. Podoplanin was also strongly expressed by granulosa cells in normal ovarian follicles, and by ovarian dysgerminomas and granulosa cell tumors. Although podoplanin was primarily absent from normal human epidermis, its expression was strongly induced in 22 of 28 squamous cell carcinomas studied. These findings suggest a potential role of podoplanin in tumor progression, and they also identify the first commercially available antibody for the specific staining of a defined lymphatic marker in archival human tissue sections, thereby enabling more widespread studies of tumor lymphangiogenesis in human cancers.
Schacht
Vivien
V
Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Dadras
Soheil S
SS
Johnson
Louise A
LA
Jackson
David G
DG
Hong
Young-Kwon
YK
Detmar
Michael
M
D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry; D015153:Blotting, Western; D002294:Carcinoma, Squamous Cell / Q000378:metabolism*; D002460:Cell Line; D045744:Cell Line, Tumor; D003713:Dendritic Cells / Q000378:metabolism; D018450:Disease Progression; D004797:Enzyme-Linked Immunosorbent Assay; D004848:Epithelium / Q000378:metabolism; D005260:Female; D006023:Glycoproteins / Q000096:biosynthesis*; D006106:Granulosa Cell Tumor / Q000378:metabolism; D006107:Granulosa Cells / Q000378:metabolism; D006801:Humans; D008208:Lymphatic System / Q000196:embryology; D008562:Membrane Glycoproteins / Q000096:biosynthesis*; D051379:Mice; D008856:Microscopy, Fluorescence; D009077:Mucins / Q000378:metabolism*; D009373:Neoplasms, Germ Cell and Embryonal / Q000378:metabolism*; D010053:Ovary / Q000378:metabolism; D034741:RNA, Small Interfering / Q000378:metabolism; D051381:Rats; D011993:Recombinant Fusion Proteins / Q000737:chemistry; D014162:Transfection; D015854:Up-Regulation; D000098853:Podoplanin
D000911:Antibodies, Monoclonal; D006023:Glycoproteins; D008562:Membrane Glycoproteins; D009077:Mucins; D034741:RNA, Small Interfering; D011993:Recombinant Fusion Proteins; C490441:Pdpn protein, mouse; D000098853:Podoplanin; C117468:PDPN protein, human; C092025:Pdpn protein, rat
Verh Dtsch Ges Pathol. 1999;83:270-5
10714221
Biochem J. 1997 Aug 15;326 ( Pt 1):99-108
9337856
Br J Cancer. 1999 May;80(3-4):569-78
10408868
Biochim Biophys Acta. 1998 Dec 8;1429(1):208-16
9920397
Biochem J. 1999 Jul 15;341 ( Pt 2):277-84
10393083
Cell. 1999 Sep 17;98(6):769-78
10499794
N Engl J Med. 2000 Oct 5;343(14):1020-34
11018170
EMBO J. 2001 Feb 15;20(4):672-82
11179212
Nat Med. 2001 Feb;7(2):186-91
11175849
Nat Med. 2001 Feb;7(2):192-8
11175850
Cancer Res. 2001 Mar 1;61(5):1786-90
11280723
J Biol Chem. 2001 Jun 1;276(22):19420-30
11278811
Microsc Res Tech. 2001 Oct 15;55(2):122-45
11596157
Cancer Res. 2001 Nov 15;61(22):8079-84
11719431
EMBO J. 2002 Apr 2;21(7):1505-13
11927535
FASEB J. 2002 Jul;16(9):922-34
12087053
Lab Invest. 2002 Sep;82(9):1255-7
12218087
Dev Dyn. 2002 Nov;225(3):351-7
12412020
Clin Cancer Res. 2003 Jan;9(1):250-6
12538477
Am J Pathol. 2003 Feb;162(2):575-86
12547715
Cancer Res. 2003 Apr 15;63(8):1920-6
12702584
Am J Pathol. 2003 Jun;162(6):1951-60
12759251
EMBO J. 2003 Jul 15;22(14):3546-56
12853470
Nat Immunol. 2004 Jan;5(1):74-80
14634646
Biochim Biophys Acta. 1988 Jun 30;970(2):146-56
3382696
Cell Growth Differ. 1990 Nov;1(11):511-8
2088477
J Exp Med. 1992 Nov 1;176(5):1477-82
1402691
Dev Biol. 1995 Jan;167(1):294-306
7851650
Am J Respir Cell Mol Biol. 1996 Jun;14(6):577-85
8652186
Bone. 1996 Feb;18(2):125-32
8833206
J Biol Chem. 1997 Mar 7;272(10):6621-8
9045692
Mol Carcinog. 1997 Sep;20(1):10-8
9328432
Am J Pathol. 1997 Oct;151(4):1141-52
9327748
J Cell Biol. 1999 Feb 22;144(4):789-801
10037799